Ensayos clínicos

8.676 ensayos encontrados

ReclutandoFase 3ClinicalTrials.gov

An Open-label Extension Trial of the Long-term Safety and Efficacy of BI 1015550 Taken Orally in Patients With Idiopathic Pulmonary Fibrosis (IPF) and Progressive Pulmonary Fibrosis (PPF) (FIBRONEER™-ON)

INTERVENTIONALInicio: 6 de may de 2024ID: NCT06238622

ReclutandoFase 3ClinicalTrials.gov

A Phase 3 Open-Label, Randomized Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN-CLL-314)

INTERVENTIONALInicio: 22 de jul de 2022ID: NCT05254743

ReclutandoFase 2ClinicalTrials.gov

An Open-label, Single-arm Study to Evaluate Pharmacokinetics, Pharmacodynamic Effects, Safety and Tolerability of Fenebrutinib in Children and Adolescents With Relapsing Multiple Sclerosis

INTERVENTIONALInicio: 6 de oct de 2025ID: NCT07161258

ReclutandoFase 3ClinicalTrials.gov

A Phase 3, Two-stage, Randomized, Multi-center, Controlled, Open-label Study Comparing Iberdomide Maintenance to Lenalidomide Maintenance Therapy After Autologous Stem Cell Transplantation (ASCT) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) (EXCALIBER-Maintenance)

INTERVENTIONALInicio: 22 de jun de 2023ID: NCT05827016

ReclutandoFase 2ClinicalTrials.gov

A Randomized Phase II, Double-blind, Multicenter Study Evaluating the Efficacy and Safety of Autogene Cevumeran Plus Nivolumab Versus Nivolumab as Adjuvant Therapy in Patients With High-risk Muscle-invasive Urothelial Carcinoma

INTERVENTIONALInicio: 9 de dic de 2024ID: NCT06534983

ReclutandoFase 3ClinicalTrials.gov

A Phase IIIB, Long-Term Follow-Up of CAB LA for Participants in HPTN 083 and HPTN 084 CAB PrEP Studies at Risk of HIV Acquisition

INTERVENTIONALInicio: 14 de may de 2024ID: NCT06134362

ReclutandoFase 3ClinicalTrials.gov

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for the Treatment of Cognitive Impairment Associated With Mild to Moderate Alzheimer's Disease (MINDSET 2)

INTERVENTIONALInicio: 21 de jul de 2025ID: NCT06976203

ReclutandoFase 3ClinicalTrials.gov

A Phase 2/3 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Atumelnant Treatment in Pediatric Participants With Congenital Adrenal Hyperplasia Including a Long-Term Extension

INTERVENTIONALInicio: 22 de ene de 2026ID: NCT07159841

ReclutandoFase 3ClinicalTrials.gov

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants With Immunoglobulin A Nephropathy (IgAN)

INTERVENTIONALInicio: 29 de mar de 2024ID: NCT06291376

ReclutandoFase 3ClinicalTrials.gov

A Phase 3, Multicenter, Open-label, Basket, LTE Study to Evaluate the Safety of Guselkumab in Pediatric Participants With Crohn's Disease, Ulcerative Colitis, or Juvenile Psoriatic Arthritis

INTERVENTIONALInicio: 29 de oct de 2024ID: NCT06663332

ReclutandoFase 3ClinicalTrials.gov

Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo for the Treatment of Obesity and Weight-Related Comorbidities in Adolescents: A Randomized, Double-Blind, Placebo- Controlled Trial (SURMOUNT-ADOLESCENTS-2)

INTERVENTIONALInicio: 3 de jun de 2024ID: NCT06439277

ReclutandoFase 3ClinicalTrials.gov

A Multi-centre, Randomised, Placebo-controlled, Double-blind, Parallel-group Trial to Evaluate Safety and Efficacy of Spesolimab (BI 655130) in Adult Patients With Ulcerative Pyoderma Gangrenosum (PG) Who Require Systemic Therapy

INTERVENTIONALInicio: 4 de feb de 2025ID: NCT06624670

ReclutandoClinicalTrials.gov

Measurement of the Diaphragm Loading During the Training With a Inspiratory Muscle Trainer Device

OBSERVATIONALInicio: 6 de feb de 2024ID: NCT05542069

ReclutandoFase 3ClinicalTrials.gov

A Phase 3, Randomized, Open-label, Active-Comparator-Controlled Clinical Study to Evaluate the Safety and Efficacy of Bomedemstat (MK-3543/IMG-7289) Versus Best Available Therapy (BAT) in Participants With Essential Thrombocythemia Who Have an Inadequate Response to or Are Intolerant of Hydroxyurea

INTERVENTIONALInicio: 31 de dic de 2023ID: NCT06079879

ReclutandoFase 3ClinicalTrials.gov

AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 3, RANDOMIZED, DOUBLE-BLIND, 3-ARM STUDY TO INVESTIGATE IBUZATRELVIR IN ADULTS WITH SYMPTOMATIC COVID-19 WHO ARE SEVERELY IMMUNOCOMPROMISED

INTERVENTIONALInicio: 14 de jul de 2025ID: NCT07013474

ReclutandoFase 2ClinicalTrials.gov

Efectividad Del Plasma Rico en Plaquetas (PRP) Para la disminución Objetiva Del Dolor y la recuperación Funcional Del Miembro Inferior en Osteoartritis de Rodilla. Evaluación de Alternativas metodológicas

INTERVENTIONALInicio: 1 de may de 2024ID: NCT05825105

ReclutandoFase 3ClinicalTrials.gov

A Multicenter, Randomized, Double-Blind Placebo-Controlled Phase 3 Study to Evaluate the Pharmacokinetics, Efficacy and Safety of Deucravacitinib (BMS-986165) in Pediatric Subjects With Moderate to Severe Plaque Psoriasis

INTERVENTIONALInicio: 23 de mar de 2021ID: NCT04772079

ReclutandoFase 3ClinicalTrials.gov

A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Tarlatamab Therapy in Subjects With Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Who Have Not Progressed Following Concurrent Chemoradiation Therapy

INTERVENTIONALInicio: 20 de feb de 2024ID: NCT06117774

ReclutandoFase 2ClinicalTrials.gov

Phase 2, Randomized, Double-Blind, Placebo-controlled, Parallel-Group, Multicenter Study to Evaluate the Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (I TRANSCEND)

INTERVENTIONALInicio: 26 de nov de 2025ID: NCT07160608

ReclutandoClinicalTrials.gov

Effects of Low-load Resistance Training With Blood Flow Restriction in Patients With Achilles Tendinopathy

INTERVENTIONALInicio: 29 de abr de 2022ID: NCT05241197